Supernus Pharmaceuticals (S49) Q1 2026 Earnings Report
DE:S49 Q1 2026 EPS Results
- Actual EPS
- EUR 0.54
- Consensus EPS
- EUR 0.27
- Beat/Miss
- Beat by +EUR 0.27
- One Year Ago EPS
- EUR 0.39
DE:S49 Q1 2026 Revenue Results
- Actual Revenue
- EUR 185.98M
- Expected Revenue
- EUR 172.74M
- Beat/Miss
- Beat by +EUR 13.24M
- YoY Revenue Growth
- +38.63%
Earnings Announcement Details
- Quarter
- Q1 2026
- Date
- 05/05/2026
- Time
- After Close
- Conference Call
- Tuesday, May 5, 2026
DE:S49 Upcoming Earnings
Supernus Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q1 2026 Earnings Call Audio
DE:S49 Q1 2026 Earnings Call
0:00 / 0:00
Q1 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:S49 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | 0.93- | 0.76 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.440.83 | 0.9 | -8.26% (-0.07) | |
| Aug 03, 2026 | 2026 (Q2) | 0.380.47 | 0.81 | -42.07% (-0.34) | |
| May 05, 2026 | 2026 (Q1) | 0.270.54 | 0.39 | 37.44% (+0.15) | |
| Feb 24, 2026 | 2025 (Q4) | 0.300.76 | 0.67 | 13.40% (+0.09) | |
| Nov 04, 2025 | 2025 (Q3) | 0.530.90 | 1.05 | -13.96% (-0.15) | |
| Aug 05, 2025 | 2025 (Q2) | 0.420.81 | 0.69 | 17.77% (+0.12) | |
| May 06, 2025 | 2025 (Q1) | 0.330.39 | 0.41 | -4.78% (-0.02) | |
| Feb 25, 2025 | 2024 (Q4) | 0.470.67 | 0.79 | -15.52% (-0.12) | |
| Nov 04, 2024 | 2024 (Q3) | 0.401.05 | -0.26 | 502.76% (+1.31) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
